BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16277027)

  • 21. Substituted steroidal compounds containing amino and amido groups reverse multidrug resistance of mouse T-lymphoma and two human prostate cancer cell lines in vitro.
    Csonka Á; Hamdoun S; Spengler G; Martins A; Vincze I; Efferth T; Molnár J
    Anticancer Res; 2015 Apr; 35(4):2105-12. PubMed ID: 25862866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cinnamylidene ketones as potential modulators of multidrug resistance in mouse lymphoma and human colon cancer cell lines.
    Engi H; Gyémánt N; Lóránd T; Lévai A; Ocsovszki I; Molnár J
    In Vivo; 2006; 20(1):119-24. PubMed ID: 16433039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour-specific cytotoxicity and MDR-reversal activity of dihydropyridines.
    Engi H; Sakagami H; Kawase M; Parecha A; Manvar D; Kothari H; Adlakha P; Shah A; Motohashi N; Ocsovszki I; Molnár J
    In Vivo; 2006; 20(5):637-43. PubMed ID: 17091771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New macrocyclic lathyrane diterpenes, from Euphorbia lagascae, as inhibitors of multidrug resistance of tumour cells.
    Duarte N; Gyémánt N; Abreu PM; Molnár J; Ferreira MJ
    Planta Med; 2006 Feb; 72(2):162-8. PubMed ID: 16491453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.
    Li X; Lu WL; Liang GW; Ruan GR; Hong HY; Long C; Zhang YT; Liu Y; Wang JC; Zhang X; Zhang Q
    Eur J Clin Invest; 2006 Jun; 36(6):409-18. PubMed ID: 16684125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
    Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
    Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of stereoselectivity of chemosensitizers in the reversal of multidrug resistance of mouse lymphoma cells.
    Szabó D; Molnár J
    Anticancer Res; 1998; 18(4C):3039-44. PubMed ID: 9713506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between doxorubicin and the resistance modifier stilbene on multidrug resistant mouse lymphoma and human breast cancer cells.
    Ferreira MJ; Duarte N; Gyémánt N; Radics R; Cherepnev G; Varga A; Molnár J
    Anticancer Res; 2006; 26(5A):3541-6. PubMed ID: 17094479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
    Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P
    Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of some novel benzofuran-2-yl(4,5-dihyro-3,5-substituted diphenylpyrazol-1-yl) methanones and studies on the antiproliferative effects and reversal of multidrug resistance of human MDR1-gene transfected mouse lymphoma cells in vitro.
    Parekh S; Bhavsar D; Savant M; Thakrar S; Bavishi A; Parmar M; Vala H; Radadiya A; Pandya N; Serly J; Molnár J; Shah A
    Eur J Med Chem; 2011 May; 46(5):1942-8. PubMed ID: 21396744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells.
    Ji BS; He L
    J Pharm Pharmacol; 2007 Jul; 59(7):1011-5. PubMed ID: 17637197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-Jun-NH2-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells.
    Takada E; Hata K; Mizuguchi J
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):569-76. PubMed ID: 18026729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids.
    Gyémánt N; Tanaka M; Molnár P; Deli J; Mándoky L; Molnár J
    Anticancer Res; 2006; 26(1A):367-74. PubMed ID: 16475720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells.
    Shen J; Zhang W; Wu J; Zhu Y
    Int J Hyperthermia; 2008 Mar; 24(2):151-9. PubMed ID: 18283591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of selected flavonoids and carotenoids on drug accumulation and apoptosis induction in multidrug-resistant colon cancer cells expressing MDR1/LRP.
    Ugocsai K; Varga A; Molnár P; Antus S; Molnár J
    In Vivo; 2005; 19(2):433-8. PubMed ID: 15796208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chinese herbs of Shenghe Powder reverse multidrug resistance of gastric carcinoma SGC-7901.
    Wang J; Xia Y; Wang H; Hou Z
    Integr Cancer Ther; 2007 Dec; 6(4):400-4. PubMed ID: 18048888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
    Bisi A; Meli M; Gobbi S; Rampa A; Tolomeo M; Dusonchet L
    Bioorg Med Chem; 2008 Jul; 16(13):6474-82. PubMed ID: 18522868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The modulating effect of proapoptotic protein Bax on the resistance of malignant lymphoma cells to tumor necrosis factor related apoptosis inducing ligand-induced apoptosis].
    Hao JH; Yu M; Jia L; Liu FT; Li Q; Hao XS
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):134-7. PubMed ID: 17418025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New MDR modulators and apoptosis inducers from Euphorbia species.
    Engi H; Vasas A; Rédei D; Molnár J; Hohmann J
    Anticancer Res; 2007; 27(5A):3451-8. PubMed ID: 17970094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line.
    Ferreira MJ; Gyémánt N; Madureira AM; Tanaka M; Koós K; Didziapetris R; Molnár J
    Anticancer Res; 2005; 25(6B):4173-8. PubMed ID: 16309213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.